Submission to FDA of a Protocol Designed to Study the Use of MDMA

As part of its submission to FDA of a protocol designed to study the use of MDMA in the treatment of PTSD, MAPS’ commissioned an extensive review of the scientific literature on MDMA. This literature review was developed under the direction of Matt Baggott with Ilsa Jerome, Ph.D., and is now being made available to regulatory agencies, other researchers and the public. The literature review will be updated on a regular basis as new research is published.